Clinical Trial Update: Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the immunogenicity and safety of a freeze-dried rabies vaccine produced on Vero cells in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Rabies (Healthy Volunteers) | Phase 3 | Status: COMPLETED